Zoetis Inc. (ZTS)

128.07
0.14 0.11
NYSE : Health Technology
Prev Close 127.93
Open 128.83
Day Low/High 128.06 / 129.02
52 Wk Low/High 78.90 / 130.20
Volume 890.13K
Avg Volume 1.92M
Exchange NYSE
Shares Outstanding 477.56M
Market Cap 61.47B
EPS 3.00
P/E Ratio 45.48
Div & Yield 0.66 (0.49%)

Latest News

Kristin Peck Will Succeed Juan Ramón Alaix As Chief Executive Officer Of Zoetis, Effective January 1, 2020, And Join The Board Of Directors, Effective Immediately. (Photo: Zoetis)

Kristin Peck Will Succeed Juan Ramón Alaix As Chief Executive Officer Of Zoetis, Effective January 1, 2020, And Join The Board Of Directors, Effective Immediately. (Photo: Zoetis)

Zoetis Inc. (NYSE: ZTS) today announced that Kristin Peck will succeed Juan Ramón Alaix as Chief Executive Officer, effective January 1, 2020, and join the Board of Directors, effective immediately.

Zoetis To Host Webcast And Conference Call On Third Quarter 2019 Financial Results

Zoetis To Host Webcast And Conference Call On Third Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis Named A Top Company For Working Mothers

Zoetis Named A Top Company For Working Mothers

Zoetis Inc. (NYSE: ZTS) today announced that it has been named one of Working Mother magazine's "100 Best Companies for Working Mothers" for the sixth consecutive year.

European Commission Grants Marketing Authorisation To Simparica Trio™, A Once-Monthly Triple Combination Antiparasitic Medication For Dogs

European Commission Grants Marketing Authorisation To Simparica Trio™, A Once-Monthly Triple Combination Antiparasitic Medication For Dogs

Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted marketing authorisation for Simparica Trio™ (sarolaner/moxidectin/pyrantel) chewable tablets, a once-monthly triple combination antiparasitic medication for dogs with, or at...

Zoetis Scientists Present Positive Efficacy Data For Investigational Triple Combination Parasiticide At American Heartworm Society Meeting

Zoetis Scientists Present Positive Efficacy Data For Investigational Triple Combination Parasiticide At American Heartworm Society Meeting

Zoetis Inc. today announced that its scientists presented positive efficacy data for the company's investigational, triple combination parasiticide product at the 2019 Triennial meeting of the American Heartworm Society (AHS) in New Orleans, La.

Zoetis To Participate In The Bank Of America Merrill Lynch Global Healthcare Conference

Zoetis To Participate In The Bank Of America Merrill Lynch Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept.

These 2 Companies Could Be More Than Pet Projects for Investors

These 2 Companies Could Be More Than Pet Projects for Investors

IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.

Let's Make a Deal: Cramer's 'Mad Money' Recap (Monday 8/26/19)

Let's Make a Deal: Cramer's 'Mad Money' Recap (Monday 8/26/19)

Jim Cramer says a quick trade deal is unlikely, and investors need to filter out the day-to-day noise.

Zoetis To Participate In The Morgan Stanley 17th Annual Global Healthcare Conference

Zoetis To Participate In The Morgan Stanley 17th Annual Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, Sept.

Zoetis Completes Acquisition Of Platinum Performance, A Leading Nutrition-Focused Animal Health Business

Zoetis Completes Acquisition Of Platinum Performance, A Leading Nutrition-Focused Animal Health Business

Zoetis Inc. (NYSE: ZTS) today announced the completion of the acquisition of Platinum Performance, a privately-held nutrition-focused animal heath company, after fulfilling all closing requirements.

A Market in Correction, U.S./China Gang War, Apple Exposed: Market Recon

A Market in Correction, U.S./China Gang War, Apple Exposed: Market Recon

The uptrend that technicians would have confirmed as late as last Wednesday, or even Thursday around mid-day, is now clearly a market in correction.

Zoetis Announces Second Quarter 2019 Results

Zoetis Announces Second Quarter 2019 Results

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the second quarter of 2019 and raised its guidance for full year 2019.

Zoetis Announces The Acquisition Of Platinum Performance, A Leading Nutrition-Focused Animal Health Business For Equine And Petcare Markets

Zoetis Announces The Acquisition Of Platinum Performance, A Leading Nutrition-Focused Animal Health Business For Equine And Petcare Markets

Zoetis Inc. (NYSE: ZTS) today announced it has entered into an agreement to acquire Platinum Performance, a privately held, nutrition-focused animal health company.

Zoetis To Host Webcast And Conference Call On Second Quarter 2019 Financial Results

Zoetis To Host Webcast And Conference Call On Second Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Prepare for the Next Bear Market With These Top All-Weather Stocks and ETFs

Prepare for the Next Bear Market With These Top All-Weather Stocks and ETFs

The only effective way to deal with a bear market is to prepare for it ahead of time.

Zoetis Broke Out to a New High - Hold Longs, Raise Stop Protection

Zoetis Broke Out to a New High - Hold Longs, Raise Stop Protection

Let's check the charts of this animal health company.

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

By going after friendly trading partners and big tech Trump is forcing Wall Street to re-calibrate and lower valuations, Jim Cramer says.

Zoetis To Participate In The William Blair 39th Annual Growth Stock Conference

Zoetis To Participate In The William Blair 39th Annual Growth Stock Conference

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 39 th Annual Growth Stock Conference on Thursday, June 6, 2019, in Chicago, Ill.

Zoetis To Participate In The Stifel 2019 Dental & Veterinary Conference

Zoetis To Participate In The Stifel 2019 Dental & Veterinary Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29, 2019, in New York, N.

Zoetis Announces Results Of Its Annual Meeting Of Shareholders; Board Declares Third Quarter 2019 Dividend

Zoetis Announces Results Of Its Annual Meeting Of Shareholders; Board Declares Third Quarter 2019 Dividend

Zoetis Inc. (NYSE:ZTS) today announced the results of shareholder voting at its 2019 Annual Meeting of Shareholders and provided details on its third quarter 2019 dividend.

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer takes a look at Wheaton Precious Metals, Cirrus Logic, PetMed Express, Knight Transportation, Chart Industries and more.

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.

Zoetis Announces First Quarter 2019 Results

Zoetis Announces First Quarter 2019 Results

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2019 and updated its guidance for full year 2019.

Forbes Names Zoetis One Of America's Best Employers For Fourth Year In A Row

Forbes Names Zoetis One Of America's Best Employers For Fourth Year In A Row

Zoetis Inc. (NYSE: ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the fourth year in a row, ranking among the top 150 companies.

Zoetis Becomes #214 Most Shorted S&P 500 Component, Replacing Discovery

Zoetis Becomes #214 Most Shorted S&P 500 Component, Replacing Discovery

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.

Zoetis To Host Webcast And Conference Call On First Quarter 2019 Financial Results

Zoetis To Host Webcast And Conference Call On First Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

TheStreet Quant Rating: B+ (Buy)